• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人重症监护病房中的早发性念珠菌血症

Early-Onset Candidemia in Adult Intensive Care Units.

作者信息

Mouratidou Christina, Tsakiri Kalliopi, Dourliou Vasiliki, Marneri Alexandra, Stougianni Maria, Pavlidis Efstathios

机构信息

Department of Adult Intensive Care Unit, Ippokrateio General Hospital, 54642 Thessaloniki, Greece.

Second Propedeutical Department of Surgery, Medical School, Aristotle University of Thessaloniki, Ippokrateio General Hospital, 54642 Thessaloniki, Greece.

出版信息

Diagnostics (Basel). 2025 May 31;15(11):1402. doi: 10.3390/diagnostics15111402.

DOI:10.3390/diagnostics15111402
PMID:40506974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12155259/
Abstract

Candidemia is a significant cause of morbidity and mortality among critically ill patients. Early-onset candidemia is characterized by occurring within the first seven days after admission to the Intensive Care Unit and presents several important challenges regarding its management. Risk factors may vary among patients with early- and late-onset infection, while clinical manifestations are generally non-specific and covered by the underlying disease and co-morbidities. Diagnosis and appropriate therapy are frequently delayed, with a high risk of progression to invasive, deep-seated infections, leading to rapid clinical deterioration. Management strategies to optimize the approach for patients with early-onset candidemia include the use of both conventional and novel diagnostic techniques, the initiation of appropriate antifungal therapy, administration of an adequate dose, daily evaluation of clinical response, de-escalation treatment whenever possible, and early discontinuation. Incorporating an antifungal stewardship program in clinical practice is essential in order to achieve the best clinical outcomes. Based on a review and analysis of the available literature, this article provides a thorough update on the risk factors, clinical characteristics, diagnostic methods, and management of early-onset candidemia in adult critically ill patients.

摘要

念珠菌血症是重症患者发病和死亡的重要原因。早发性念珠菌血症的特点是在入住重症监护病房后的头七天内发生,其管理面临若干重要挑战。早发性和晚发性感染患者的危险因素可能有所不同,而临床表现通常无特异性,被基础疾病和合并症所掩盖。诊断和适当治疗常常延迟,进展为侵袭性深部感染的风险很高,导致临床迅速恶化。优化早发性念珠菌血症患者治疗方法的管理策略包括使用传统和新型诊断技术、启动适当的抗真菌治疗、给予足够剂量、每日评估临床反应、尽可能进行降阶梯治疗以及尽早停药。在临床实践中纳入抗真菌管理计划对于实现最佳临床结果至关重要。基于对现有文献的综述和分析,本文全面更新了成人重症患者早发性念珠菌血症的危险因素、临床特征、诊断方法和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f03/12155259/fec62759d3d6/diagnostics-15-01402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f03/12155259/fec62759d3d6/diagnostics-15-01402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f03/12155259/fec62759d3d6/diagnostics-15-01402-g001.jpg

相似文献

1
Early-Onset Candidemia in Adult Intensive Care Units.成人重症监护病房中的早发性念珠菌血症
Diagnostics (Basel). 2025 May 31;15(11):1402. doi: 10.3390/diagnostics15111402.
2
Evaluating antimicrobial stewardship strategies in candidemia: a novel desirability of outcome ranking (DOOR) analysis comparing blood culture versus T2Candida diagnostic approaches.评估念珠菌血症中的抗菌药物管理策略:一种比较血培养与T2念珠菌诊断方法的新型结局排名合意性(DOOR)分析
J Clin Microbiol. 2025 May 14;63(5):e0004325. doi: 10.1128/jcm.00043-25. Epub 2025 Apr 11.
3
Diagnosis and Treatment of Candidemia in the Intensive Care Unit.重症监护病房念珠菌血症的诊断与治疗。
Semin Respir Crit Care Med. 2019 Aug;40(4):524-539. doi: 10.1055/s-0039-1693704. Epub 2019 Oct 4.
4
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.非中性粒细胞减少的重症患者念珠菌血症:预后因素分析及全身抗真菌治疗评估。重症监护病房真菌感染研究组
Intensive Care Med. 1997 Jan;23(1):23-30. doi: 10.1007/s001340050286.
5
Candidemia in Adult Patients in the ICU: A Reappraisal of Susceptibility Testing and Antifungal Therapy.重症监护病房成年患者的念珠菌血症:药敏试验和抗真菌治疗的重新评估
Ann Pharmacother. 2024 Mar;58(3):305-321. doi: 10.1177/10600280231175201. Epub 2023 Jun 5.
6
Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China.危重症患者念珠菌血症的流行病学、物种分布、抗真菌药敏性和死亡危险因素:2011 年至 2017 年中国一家教学医院的回顾性研究。
Antimicrob Resist Infect Control. 2019 May 29;8:89. doi: 10.1186/s13756-019-0534-2. eCollection 2019.
7
Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients.注意差距:危重症患者侵袭性念珠菌病临床管理中的挑战。
Curr Opin Infect Dis. 2020 Dec;33(6):441-448. doi: 10.1097/QCO.0000000000000684.
8
Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients.非中性粒细胞减少的重症患者严重脓毒症后念珠菌血症及相关念珠菌亚型的患病率
Acta Biomed. 2018 Jun 7;89(2):193-202. doi: 10.23750/abm.v89i2.5385.
9
Candidemia in the Intensive Care Unit.重症监护病房中的念珠菌血症
Clin Chest Med. 2017 Sep;38(3):493-509. doi: 10.1016/j.ccm.2017.04.010. Epub 2017 Jun 16.
10
Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis.德国重症患者念珠菌血症的流行病学、临床特征及转归:一项单中心10年回顾性分析
Ann Intensive Care. 2020 Oct 16;10(1):142. doi: 10.1186/s13613-020-00755-8.

本文引用的文献

1
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?重症监护病房中的侵袭性念珠菌病:我们目前的状况如何?
J Fungi (Basel). 2025 Mar 27;11(4):258. doi: 10.3390/jof11040258.
2
: A Continuing Threat.持续的威胁。
Microorganisms. 2025 Mar 13;13(3):652. doi: 10.3390/microorganisms13030652.
3
Evaluation of Serum Biomarkers for Improved Diagnosis of Candidemia.用于改善念珠菌血症诊断的血清生物标志物评估
J Fungi (Basel). 2025 Mar 15;11(3):224. doi: 10.3390/jof11030224.
4
Empirical versus pre-emptive antifungal therapies for invasive fungal infections in critically ill patients.危重症患者侵袭性真菌感染的经验性抗真菌治疗与抢先抗真菌治疗对比
BMC Infect Dis. 2025 Mar 22;25(1):395. doi: 10.1186/s12879-025-10816-7.
5
Candidemia in ICU Patients: What Are the Real Game-Changers for Survival?重症监护病房患者的念珠菌血症:生存的真正改变因素有哪些?
J Fungi (Basel). 2025 Feb 17;11(2):152. doi: 10.3390/jof11020152.
6
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.念珠菌病诊断与管理全球指南:欧洲临床微生物与感染病学会联合国际人类和动物真菌学会及美国微生物学会发起
Lancet Infect Dis. 2025 May;25(5):e280-e293. doi: 10.1016/S1473-3099(24)00749-7. Epub 2025 Feb 13.
7
CRISPR technology combined with isothermal amplification methods for the diagnosis of Candida albicans infection.用于诊断白色念珠菌感染的CRISPR技术与等温扩增方法相结合。
Clin Chim Acta. 2025 Feb 1;567:120106. doi: 10.1016/j.cca.2024.120106. Epub 2024 Dec 21.
8
Antifungal susceptibility, molecular epidemiology, and clinical risk factors of in intensive care unit in a Chinese Tertiary Hospital.中国一家三甲医院重症监护病房的临床风险因素、分子流行病学和抗真菌药敏性。
Front Cell Infect Microbiol. 2024 Oct 7;14:1455145. doi: 10.3389/fcimb.2024.1455145. eCollection 2024.
9
Evaluation of the Eazyplex ID LAMP Assay for the Rapid Diagnosis of Positive Blood Cultures.用于血培养阳性快速诊断的Eazyplex ID环介导等温扩增检测法的评估
Diagnostics (Basel). 2024 Sep 25;14(19):2125. doi: 10.3390/diagnostics14192125.
10
Multi-state evaluation of Candida infections in burn patients.烧伤患者念珠菌感染的多态性评估。
Mycoses. 2024 Aug;67(8):e13788. doi: 10.1111/myc.13788.